| Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial AH Alrefai, SK Aburahma, YS Khader Clinical neurology and neurosurgery 111 (1), 79-82, 2009 | 92 | 2009 |
| Idiopathic hypertrophic pachymeningitis in a child with hydrocephalus SK Aburahma, AGM Anabtawi, HS Al Rimawi, MA Elheis, AH Mohtaseb Pediatric neurology 40 (6), 457-460, 2009 | 31 | 2009 |
| The vagal nerve stimulation outcome, and laryngeal effect: otolaryngologists roles and perspective AI Al Omari, FQ Alzoubi, MM Alsalem, SK Aburahma, DT Mardini, ... American journal of otolaryngology 38 (4), 408-413, 2017 | 30 | 2017 |
| Complementary and alternative medicine use in a pediatric neurology clinic SK Aburahma, YS Khader, K Alzoubi, N Sawalha Complementary therapies in clinical practice 16 (3), 117-120, 2010 | 29 | 2010 |
| Parental knowledge and attitudes towards epilepsy–A study from Jordan A Masri, S Aburahma, A Khasawneh, AAL Qudah, O Nafi, M Al Momani, ... Seizure 53, 75-80, 2017 | 26 | 2017 |
| Novel mutations in WWOX, RARS2, and C10orf2 genes in consanguineous Arab families with intellectual disability AM Alkhateeb, SK Aburahma, W Habbab, IR Thompson Metabolic brain disease 31, 901-907, 2016 | 24 | 2016 |
| Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis SK Aburahma, FQ Alzoubi, HM Hammouri, A Masri Seizure 25, 167-172, 2015 | 22 | 2015 |
| Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy S Aburahma, M Khassawneh, M Griebel, G Sharp, J Gibson Journal of Child Neurology 26 (6), 703-706, 2011 | 22 | 2011 |
| Peripheral nerve dysfunction in patients with cystic fibrosis K El-Salem, S Aburahma, M Rawashdeh Journal of Clinical Neurophysiology 27 (3), 216-218, 2010 | 13 | 2010 |
| Dental health status and hygiene in children with cerebral palsy: a matched case‐control study SK Aburahma, A Mhanna, S Al‐Mousa, J Al‐Nusair, R Al Habashneh International Journal of Paediatric Dentistry 31 (6), 752-759, 2021 | 7 | 2021 |
| Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series SK Aburahma, T Al-Khateeb, A Alrefai, Z Amarin Journal of child neurology 24 (1), 5-8, 2009 | 6 | 2009 |
| Impact of COVID-19 pandemic on pediatric patients with epilepsy in Jordan: The caregiver perspective M Al Momani, BA Almomani, P Sweidan, A Al-Qudah, S Aburahma, ... Seizure 92, 100-105, 2021 | 5 | 2021 |
| Take two: Utility of the repeat skeletal muscle biopsy SK Aburahma, MP Wicklund, D Quan Muscle & Nerve 60 (1), 41-46, 2019 | 4 | 2019 |
| Social impairment in children with epilepsy assessed by the social responsiveness scale SK Aburahma, H Hammouri, E Hazaimeh, O Jbarah, A Nassar, A Almasri, ... Clinical child psychology and psychiatry 26 (4), 1170-1181, 2021 | 3 | 2021 |
| Limb girdle muscular dystrophies SK Aburahma, MP Wicklund The Curated Reference Collection in Neuroscience and Biobehavioral …, 2016 | 2 | 2016 |
| Management of Sialorrhea in Children with Cerebral Palsy A Alrefai, SK Aburahma AJCN, 2010 | 1 | 2010 |
| Sleep Problems in Children with Autism Spectrum Disorder (P1-8.003) S Aburahma, E Hazaimeh, O Jbarah, B Khassawneh Neurology 102 (17_supplement_1), 6235, 2024 | | 2024 |
| Case report: Dihydropyridine receptor (CACNA1S) congenital myopathy, a novel phenotype with early onset periodic paralysis SK Aburahma, LA Rousan, M Shboul, F Biella, S Lucchiari, GP Comi, ... Frontiers in Neurology 15, 1359479, 2024 | | 2024 |
| Chiari I malformation: Clinical Characteristics, Symptoms, and Presentations.(P10-4.005) Y Al-Zamer, S Aburahma, R Khasawneh, E Hazaimeh, O Jbarah Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| P. 10 Compound CACNA1S heterozygosity resulting in a novel phenotype of congenital myopathy and early onset periodic paralysis: report of two probands S Aburahma, M Shboul, S Lucchiari, G Comi, G Meola, S Pagliarani Neuromuscular Disorders 32, S47, 2022 | | 2022 |
